| |
|
|
|
Aslan Pharmaceuticals Ltd ADR  
|
|
1.61 -0.08 (-0.05%) |
08-14 16:00 |
|
Open: |
1.7 |
Pre close: |
1.69 |
Target:
|
2.18
|
|
High: |
1.7 |
Low: |
1.56 |
Resistance:
|
1.87
2.09
|
|
Volume: |
54,193 |
Market Cap: |
30M |
Support:
|
1.51
1.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.65
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
1.69 |
Signal(12,26,9): |
-0.06  |
|
MA(100): |
1.69 |
Stochastic Oscillator |
%K(14,3):
|
40.09 |
|
MA(250): |
1.79 |
%D(3): |
39.97 |
|
Average Volume(K) |
3-Month: |
10367
|
52-Week |
High:
|
8.18 |
|
10-Days: |
4750 |
Low: |
0.35 |
|
RSI |
RSI(14):
|
40.95 |
Change(%): |
-38.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.240 |
Return on Equity (ttm) |
-769.8 |
Shares Out. (M) |
37.99 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-41.6 |
Shares Float (M) |
36.90 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.68 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
2.101 |
Shares Short (K) |
28 |
|
Book Value (p.s.) |
-0.230 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.30 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-7.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
